Mounjaro
Mounjaro is an MHRA licensed weight management treatment for adults in the UK, and it has changed what's possible in obesity care. It's the first medication of its kind to work on two appetite hormones at once, which is part of the reason patients on the highest dose lost an average of 22.5% of their body weight over 72 weeks in clinical trials. You take it as a single injection once a week.
Is Mounjaro right for you?
Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above if you also have a weight related condition such as type 2 diabetes, high blood pressure, or raised cholesterol. To get the best from it, you'll need to combine treatment with a reduced calorie diet and more physical activity. Our clinicians will check your eligibility as part of your consultation.
How it works
The active ingredient, tirzepatide, mimics two natural gut hormones called GLP‑1 and GIP. Together they reduce your appetite, slow how quickly your stomach empties, and help you feel satisfied for longer after eating. The result is fewer cravings and a more manageable relationship with food, which makes lifestyle changes far easier to stick to.
What the clinical evidence shows
Mounjaro has been studied extensively through the SURMOUNT trial programme. Patients on the 15mg maintenance dose lost an average of 22.5% of their body weight over 72 weeks. More than nine in ten participants lost at least 5% of their starting weight, and over half lost 20% or more. Many also saw improvements in blood pressure and cholesterol along the way.
Your treatment with Rightangled
We're a regulated UK pharmacy and prescribing service, which means every Mounjaro prescription is reviewed by one of our GMC registered clinicians, not algorithms. Most assessments are reviewed the same day. Your medication is dispensed from our GPhC registered pharmacy and arrives in discreet, temperature controlled packaging, and our clinical team is available throughout your treatment if you have questions or concerns.
What's in the box
Each Mounjaro KwikPen holds four weekly doses, so one pen is one month of treatment. We include the injection needles, the official patient information leaflet, and access to our clinical support team should you need it.
Your dosing schedule
Treatment starts low and increases gradually so your body has time to adjust. You'll begin on 2.5mg once a week for the first four weeks, then move up to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as your maintenance dose. Each step lasts around four weeks, though your clinician may slow this down if you're experiencing side effects, or keep you on a lower dose if it's working well for you.
What to expect from side effects
The most common side effects are digestive: nausea, mild diarrhoea, constipation, and occasional vomiting. They're usually mild, tend to settle within a few weeks, and are most noticeable just after a dose increase. Eating smaller meals more often and avoiding rich, fatty foods makes a real difference for most people.
When Mounjaro isn't suitable
Mounjaro isn't right for everyone. You shouldn't take it if you or a close family member has a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or if you've had a serious allergic reaction to tirzepatide. It also isn't safe during pregnancy or breastfeeding, and you should stop treatment at least two months before trying to conceive.
Getting started
Start with our short online consultation. It takes around five minutes and asks about your health, medical history, and weight loss goals. One of our clinicians will review your answers, usually within hours, and if Mounjaro is suitable for you we'll dispense your prescription and send it out from our UK pharmacy with next day delivery available.
Mounjaro or Wegovy?
Both are excellent once weekly injections, but they work slightly differently. Mounjaro acts on two hormones (GLP‑1 and GIP) and showed an average 22.5% weight loss in trials. Wegovy works on GLP‑1 alone, with an average 15% weight loss. Mounjaro starts from £164.99 a month and Wegovy from £99.99. Your clinician will help you decide which is the better fit based on your goals, medical history, and budget.
Mounjaro is a prescription only medicine regulated by the MHRA and must be prescribed after a proper medical assessment. For full prescribing information, please refer to the Summary of Product Characteristics on medicines.org.uk.
This service is provided by Rightangled in partnership with Medetone pharmacy, regulated by the General Pharmaceutical Council and the Care Quality Commission. Mounjaro® is a registered trademark of Eli Lilly and Company.
Mounjaro is an MHRA licensed weight management treatment for adults in the UK, and it has changed what's possible in obesity care. It's the first medication of its kind to work on two appetite hormones at once, which is part of the reason patients on the highest dose lost an average of 22.5% of their body weight over 72 weeks in clinical trials. You take it as a single injection once a week.
Is Mounjaro right for you?
Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above if you also have a weight related condition such as type 2 diabetes, high blood pressure, or raised cholesterol. To get the best from it, you'll need to combine treatment with a reduced calorie diet and more physical activity. Our clinicians will check your eligibility as part of your consultation.
How it works
The active ingredient, tirzepatide, mimics two natural gut hormones called GLP‑1 and GIP. Together they reduce your appetite, slow how quickly your stomach empties, and help you feel satisfied for longer after eating. The result is fewer cravings and a more manageable relationship with food, which makes lifestyle changes far easier to stick to.
What the clinical evidence shows
Mounjaro has been studied extensively through the SURMOUNT trial programme. Patients on the 15mg maintenance dose lost an average of 22.5% of their body weight over 72 weeks. More than nine in ten participants lost at least 5% of their starting weight, and over half lost 20% or more. Many also saw improvements in blood pressure and cholesterol along the way.
Your treatment with Rightangled
We're a regulated UK pharmacy and prescribing service, which means every Mounjaro prescription is reviewed by one of our GMC registered clinicians, not algorithms. Most assessments are reviewed the same day. Your medication is dispensed from our GPhC registered pharmacy and arrives in discreet, temperature controlled packaging, and our clinical team is available throughout your treatment if you have questions or concerns.
What's in the box
Each Mounjaro KwikPen holds four weekly doses, so one pen is one month of treatment. We include the injection needles, the official patient information leaflet, and access to our clinical support team should you need it.
Your dosing schedule
Treatment starts low and increases gradually so your body has time to adjust. You'll begin on 2.5mg once a week for the first four weeks, then move up to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as your maintenance dose. Each step lasts around four weeks, though your clinician may slow this down if you're experiencing side effects, or keep you on a lower dose if it's working well for you.
What to expect from side effects
The most common side effects are digestive: nausea, mild diarrhoea, constipation, and occasional vomiting. They're usually mild, tend to settle within a few weeks, and are most noticeable just after a dose increase. Eating smaller meals more often and avoiding rich, fatty foods makes a real difference for most people.
When Mounjaro isn't suitable
Mounjaro isn't right for everyone. You shouldn't take it if you or a close family member has a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or if you've had a serious allergic reaction to tirzepatide. It also isn't safe during pregnancy or breastfeeding, and you should stop treatment at least two months before trying to conceive.
Getting started
Start with our short online consultation. It takes around five minutes and asks about your health, medical history, and weight loss goals. One of our clinicians will review your answers, usually within hours, and if Mounjaro is suitable for you we'll dispense your prescription and send it out from our UK pharmacy with next day delivery available.
Mounjaro or Wegovy?
Both are excellent once weekly injections, but they work slightly differently. Mounjaro acts on two hormones (GLP‑1 and GIP) and showed an average 22.5% weight loss in trials. Wegovy works on GLP‑1 alone, with an average 15% weight loss. Mounjaro starts from £164.99 a month and Wegovy from £99.99. Your clinician will help you decide which is the better fit based on your goals, medical history, and budget.
Mounjaro is a prescription only medicine regulated by the MHRA and must be prescribed after a proper medical assessment. For full prescribing information, please refer to the Summary of Product Characteristics on medicines.org.uk.
This service is provided by Rightangled in partnership with Medetone pharmacy, regulated by the General Pharmaceutical Council and the Care Quality Commission. Mounjaro® is a registered trademark of Eli Lilly and Company.
Original: $220.04
-65%$220.04
$77.01Description
Mounjaro is an MHRA licensed weight management treatment for adults in the UK, and it has changed what's possible in obesity care. It's the first medication of its kind to work on two appetite hormones at once, which is part of the reason patients on the highest dose lost an average of 22.5% of their body weight over 72 weeks in clinical trials. You take it as a single injection once a week.
Is Mounjaro right for you?
Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above if you also have a weight related condition such as type 2 diabetes, high blood pressure, or raised cholesterol. To get the best from it, you'll need to combine treatment with a reduced calorie diet and more physical activity. Our clinicians will check your eligibility as part of your consultation.
How it works
The active ingredient, tirzepatide, mimics two natural gut hormones called GLP‑1 and GIP. Together they reduce your appetite, slow how quickly your stomach empties, and help you feel satisfied for longer after eating. The result is fewer cravings and a more manageable relationship with food, which makes lifestyle changes far easier to stick to.
What the clinical evidence shows
Mounjaro has been studied extensively through the SURMOUNT trial programme. Patients on the 15mg maintenance dose lost an average of 22.5% of their body weight over 72 weeks. More than nine in ten participants lost at least 5% of their starting weight, and over half lost 20% or more. Many also saw improvements in blood pressure and cholesterol along the way.
Your treatment with Rightangled
We're a regulated UK pharmacy and prescribing service, which means every Mounjaro prescription is reviewed by one of our GMC registered clinicians, not algorithms. Most assessments are reviewed the same day. Your medication is dispensed from our GPhC registered pharmacy and arrives in discreet, temperature controlled packaging, and our clinical team is available throughout your treatment if you have questions or concerns.
What's in the box
Each Mounjaro KwikPen holds four weekly doses, so one pen is one month of treatment. We include the injection needles, the official patient information leaflet, and access to our clinical support team should you need it.
Your dosing schedule
Treatment starts low and increases gradually so your body has time to adjust. You'll begin on 2.5mg once a week for the first four weeks, then move up to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as your maintenance dose. Each step lasts around four weeks, though your clinician may slow this down if you're experiencing side effects, or keep you on a lower dose if it's working well for you.
What to expect from side effects
The most common side effects are digestive: nausea, mild diarrhoea, constipation, and occasional vomiting. They're usually mild, tend to settle within a few weeks, and are most noticeable just after a dose increase. Eating smaller meals more often and avoiding rich, fatty foods makes a real difference for most people.
When Mounjaro isn't suitable
Mounjaro isn't right for everyone. You shouldn't take it if you or a close family member has a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or if you've had a serious allergic reaction to tirzepatide. It also isn't safe during pregnancy or breastfeeding, and you should stop treatment at least two months before trying to conceive.
Getting started
Start with our short online consultation. It takes around five minutes and asks about your health, medical history, and weight loss goals. One of our clinicians will review your answers, usually within hours, and if Mounjaro is suitable for you we'll dispense your prescription and send it out from our UK pharmacy with next day delivery available.
Mounjaro or Wegovy?
Both are excellent once weekly injections, but they work slightly differently. Mounjaro acts on two hormones (GLP‑1 and GIP) and showed an average 22.5% weight loss in trials. Wegovy works on GLP‑1 alone, with an average 15% weight loss. Mounjaro starts from £164.99 a month and Wegovy from £99.99. Your clinician will help you decide which is the better fit based on your goals, medical history, and budget.
Mounjaro is a prescription only medicine regulated by the MHRA and must be prescribed after a proper medical assessment. For full prescribing information, please refer to the Summary of Product Characteristics on medicines.org.uk.
This service is provided by Rightangled in partnership with Medetone pharmacy, regulated by the General Pharmaceutical Council and the Care Quality Commission. Mounjaro® is a registered trademark of Eli Lilly and Company.
